Search hospitals > Indiana > Indianapolis

Ascension Saint Vincent Indianapolis Hospital

Claim this profile
Indianapolis, Indiana 46260
Global Leader in Parotid Gland Cancer
Global Leader in Relapse
Conducts research for Cancer
Conducts research for Ovarian Cancer
Conducts research for Adult T-Cell Leukemia/Lymphoma
336 reported clinical trials
11 medical researchers
Photo of Ascension Saint Vincent Indianapolis Hospital in Indianapolis

Summary

Ascension Saint Vincent Indianapolis Hospital is a medical facility located in Indianapolis, Indiana. This center is recognized for care of Parotid Gland Cancer, Relapse, Cancer, Ovarian Cancer, Adult T-Cell Leukemia/Lymphoma and other specialties. Ascension Saint Vincent Indianapolis Hospital is involved with conducting 336 clinical trials across 522 conditions. There are 11 research doctors associated with this hospital, such as Bassem I. Razzouk, Ashwin Ravichandran, MD, Michael Callahan, MD, and James Hermiller, MD.

Area of expertise

1Parotid Gland Cancer
Global Leader
Ascension Saint Vincent Indianapolis Hospital has run 63 trials for Parotid Gland Cancer. Some of their research focus areas include:
Stage I
Stage IV
Stage II
2Relapse
Global Leader
Ascension Saint Vincent Indianapolis Hospital has run 63 trials for Relapse. Some of their research focus areas include:
Stage IV
Stage III
Stage I

Top PIs

Clinical Trials running at Ascension Saint Vincent Indianapolis Hospital

Ovarian Cancer
Uterine Cancer
Testicular cancer
Acute Lymphoblastic Leukemia
Lung Cancer
Endometrial Cancer
Cardiovascular Disease
Rhabdomyosarcoma
Cancer
Parotid Gland Cancer
Image of trial facility.

Olaparib +/- Bevacizumab

for Ovarian Cancer

This phase III trial compares the effect of olaparib for one year versus two years, with or without bevacizumab, for the treatment of BRCA 1/2 mutated or homologous recombination deficient stage III or IV ovarian cancer. Olaparib is a polyadenosine 5'-diphosphoribose polymerase (PARP) enzyme inhibitor and may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Bevacizumab is in a class of medications called antiangiogenic agents. It works by stopping the formation of blood vessels that bring oxygen and nutrients to tumor. This may slow the growth and spread of tumor. Giving olaparib for one year with or without bevacizumab may be effective in treating patients with BRCA 1/2 mutated or homologous recombination deficient stage III or IV ovarian cancer, when compared to two years of olaparib.
Recruiting2 awards Phase 34 criteria
Image of trial facility.

Mirvetuximab + Bevacizumab

for Ovarian Cancer

GLORIOSA is a Phase 3 multicenter, open label study designed to evaluate the safety and efficacy of mirvetuximab Soravtansine + Bevacizumab as maintenance therapy in participants with platinum-sensitive ovarian, primary peritoneal or fallopian tube cancers with high folate receptor-alpha (FRα) expression.
Recruiting2 awards Phase 3
Image of trial facility.

Surgical Procedures

for Reducing Ovarian Cancer Risk

This clinical trial evaluates how well two surgical procedures (bilateral salpingectomy and bilateral salpingo-oophorectomy) work in reducing the risk of ovarian cancer for individuals with BRCA1 mutations. Bilateral salpingectomy involves the surgical removal of fallopian tubes, and bilateral salpingo-oophorectomy involves the surgical removal of both the fallopian tubes and ovaries. This study may help doctors determine if the two surgical procedures are nearly the same for ovarian cancer risk reduction for women with BRCA1 mutations.
Recruiting1 award N/A

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Ascension Saint Vincent Indianapolis Hospital?
Where is Ascension Saint Vincent Indianapolis Hospital located?
Who should I call to ask about financial aid or insurance network?
What insurance does Ascension Saint Vincent Indianapolis Hospital accept?
What awards or recognition has Ascension Saint Vincent Indianapolis Hospital received?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security